- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02898246
Fear of Activity in Situations (FActS) - Study 2016
Fear of Activity in Situations (FActS) - Heart Failure Study 2016
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Aachen, Germany
- Universitätsklinikum Aachen
-
Homburg, Germany
- Universitätsklinikum des Saarlands
-
Trier, Germany, 54290
- Mutterhaus der Borromäerinnen
-
Trier, Germany
- Krankenhaus der Barmherzigen Bruder Trier
-
Trier, Germany
- Geriatrische Rehabilitationsklinik St. Irminen
-
Würselen, Germany, 52146
- Rhein-Maas-Klinikum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Clinical diagnosis of heart failure stage B or C (Hunt et al., 2005), or: New York Heart Failure classification II to IIIb:
- Systolic dysfunction: left ventricular ejection fraction < 45% in the last 6 month
- Diastolic dysfunction: left ventricular ejection fraction >= 45% in the last 6 month
Exclusion Criteria:
- complex ventricular arrhythmias
- acute myocarditis
- symptomatic cardiac valve stenosis
- instable angina pectoris
- other severe diseases, that impair physical activity (e.g., advanced stages of cancer)
- insufficient language skills in German to answer the questionnaires
- insufficient cognitive skills to answer the questionnaires
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients with chronic heart failure
Fear of physical activity (exposure) will be assessed in adult outpatients with diagnosed, chronic heart failure (with reduced ejection fraction or with preserved ejection fraction). Hospitals provide medical data to assess patients' disease severity. Additional measures assessed via questionnaire include demographic characteristics, State and Trait depression and anxiety, heart failure related symptom distress, and coping dispositions relevant for coping with physical threat. Fear of physical activity (FActS-HF 15) is reassessed after 4 weeks to evaluate the instrument's retest reliability. After questionnaire completion, a subsample of participants will wear the MOVE III accelerometer for one week to objectively assess everyday physical activity and fill in an activity diary. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FActS-HF 15 total score and subscores
Time Frame: 2016-2019
|
The psychometric properties of FActS-HF 15 are assessed in terms of item analysis, reliability (internal consistency, test-retest reliability), convergent and discriminant validity (correlations with other questionnaires) as well as confirmatory factor analysis (assessing the dimensionality).
Associations with demographic, medical, and psychosocial variables will be evaluated.
|
2016-2019
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average daily energy expenditure due to physical activity (kcal/d)
Time Frame: 6 day assessment, after questionnaire completion
|
Objectively assessed via accelerometry
|
6 day assessment, after questionnaire completion
|
|
Average intensity of physical activity (MET)
Time Frame: 6 day assessment, after questionnaire completion
|
Objectively assessed via accelerometry
|
6 day assessment, after questionnaire completion
|
|
Average relative frequency of activity classes
Time Frame: 6 day assessment, after questionnaire completion
|
Relative frequency of activity classes stair climbing, lying down, walking
|
6 day assessment, after questionnaire completion
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heike Spaderna, PhD, Trier University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FActS Study 2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Heart Failure
-
Noah LabsHospital Clinic of Barcelona; Maastricht University; Zuyderland Medical CentreActive, not recruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseSpain, Netherlands
-
BayerCompletedChronic Heart Failure | Chronic Heart Failure With Reduced Ejection FractionJapan
-
BayerActive, not recruitingChronic Heart Failure With Reduced Ejection Fraction | Worsening Chronic Heart FailureIndia
-
Maastricht University Medical CenterUniversity Medical Center Groningen; Maastricht UniversityWithdrawnChronic Heart Failure | Acute Decompensated Heart FailureNetherlands
-
Melana Yuzefpolskaya, MDRecruitingChronic Heart FailureUnited States
-
BayerRecruitingChronic Heart FailureSouth Korea
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
CHFDX,Inc.University of South Florida; Tampa General HospitalRecruitingDecompensated Chronic Heart FailureUnited States
-
Medical University of ViennaCompleted
-
Maastricht University Medical CenterUniversity College Dublin; RWTH Aachen University; Queen's University, BelfastCompletedChronic Heart FailureNetherlands, Germany, Ireland, United Kingdom